Upgrade to SI Premium - Free Trial

Parabilis Medicines (PBLS)

40.42 -0.33 (0.81%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

Form 4 Parabilis Medicines, For: Aug 22 Filed by: Tendler Craig August 25, 2026 6:15 PM - SEC Filing Form 3 Parabilis Medicines, For: Aug 22 Filed by: Tendler Craig August 25, 2026 6:05 PM - SEC Filing Form 8-K Parabilis Medicines, For: Aug 22 August 25, 2026 4:10 PM - SEC Filing Parabilis Medicines adds former J&J oncology executive to board August 25, 2026 7:01 AM - StreetInsider Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors August 25, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G Parabilis Medicines, Filed by: ARCH Venture Fund XII, L.P. August 14, 2026 4:08 PM - SEC Filing Form 10-Q Parabilis Medicines, For: Jun 30 August 13, 2026 4:10 PM - SEC Filing Form 8-K Parabilis Medicines, For: Aug 13 August 13, 2026 7:19 AM - SEC Filing Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates August 13, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G Parabilis Medicines, Filed by: FMR LLC August 6, 2026 10:39 AM - SEC Filing Form 4 Parabilis Medicines, For: Jul 20 Filed by: Shah Rajeev M. July 22, 2026 4:56 PM - SEC Filing BofA Securities Starts Parabilis Medicines (PBLS) at Buy July 6, 2026 6:11 AM - StreetInsider Leerink Starts Parabilis Medicines (PBLS) at Outperform July 6, 2026 6:07 AM - StreetInsider Evercore ISI Starts Parabilis Medicines (PBLS) at Outperform July 6, 2026 6:04 AM - StreetInsider Guggenheim Starts Parabilis Medicines (PBLS) at Buy July 6, 2026 2:39 AM - StreetInsider Form 4 Parabilis Medicines, For: Jun 11 Filed by: Soleus Private Equity Fund III, L.P. June 29, 2026 10:41 AM - SEC Filing Form 3 Parabilis Medicines, For: Jun 09 Filed by: Soleus Private Equity Fund III, L.P. June 29, 2026 10:38 AM - SEC Filing Form SCHEDULE 13D Parabilis Medicines, Filed by: RA CAPITAL MANAGEMENT, L.P. June 18, 2026 4:10 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 12 Filed by: SEBULSKY ALAN June 16, 2026 6:19 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 11 Filed by: Shah Rajeev M. June 15, 2026 6:58 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: FITZGERALD EDWARD M June 15, 2026 5:35 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 11 Filed by: SEBULSKY ALAN June 15, 2026 5:28 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 11 Filed by: Borisy Alexis June 15, 2026 5:18 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 11 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. June 11, 2026 8:08 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: Shah Rajeev M. June 11, 2026 6:36 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: Borisy Alexis June 11, 2026 4:53 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: Weber Barbara June 11, 2026 4:53 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: Yeshwant Krishna June 11, 2026 4:52 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: FITZGERALD EDWARD M June 11, 2026 4:48 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: Simson Jake June 11, 2026 4:48 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: Klausner Richard June 11, 2026 4:43 PM - SEC Filing Form 4 Parabilis Medicines, For: Jun 09 Filed by: SEBULSKY ALAN June 11, 2026 4:41 PM - SEC Filing Form 8-K Parabilis Medicines, For: Jun 09 June 11, 2026 4:13 PM - SEC Filing Parabilis Medicines closes $770.5 million IPO and concurrent private placement June 11, 2026 4:05 PM - StreetInsider Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares June 11, 2026 4:05 PM - Globe NewsWire Parabilis Medicines (PBLS) Opens at $33.35, IPO priced at $20, Trading $28.31 June 10, 2026 12:52 PM - StreetInsider Parabilis Medicines prices IPO at $20 per share, raises $670 million June 9, 2026 8:22 PM - StreetInsider Parabilis Medicines Announces Pricing of Upsized Initial Public Offering June 9, 2026 8:22 PM - Globe NewsWire Parabilis Medicines targets up to $633.3M raise in upsized US IPO June 9, 2026 6:33 AM - StreetInsider Parabilis Medicines (PBLS) files for upsized 33.33 M share IPO at $17-$19/sh June 9, 2026 6:15 AM - StreetInsider Full Article List